MIE faces class-action lawsuit after cyberattack

EHR vendor Medical Informatics Engineering (MIE) is facing significant fallout from its recent cyberattack with an Indiana resident affected by the data breach filing a class-action lawsuit in federal court against the company, alleging the vendor did not adequately protect its software from a cyberattack.

On May 26, MIE discovered the attack on its main network and its subsidiary NoMoreClipboard's network that started on May 7. Information on the hacked servers included names, birthdates, email addresses; mailing addresses, medical conditions and Social Security numbers. The breach affected 3.9 million patients. 

The class-action lawsuit was filed by James Young, a patient affected by the breach, and claims MIE did not "take available steps to prevent and stop the breach from ever happening."

More than 100 plaintiffs have joined the suit which alleges that MIE failed to disclose to its customers material facts related to the breach and provide timely notice of the breach.

"As a result of the MIE data breach, numerous individuals whose [health information] was used in a MIE [EHR] have been exposed to fraud and these individuals have been harmed," the suit says. Young "suffered actual injury from having his [personally identifiable information] and [personal health information] compromised and stolen in and as a result of the MIE data breach."

Access the lawsuit.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.